Company Filing History:
Years Active: 2012
Title: Cartsen Reichel: Innovating in Quinazoline Derivatives
Introduction
Cartsen Reichel, based in Rheinboellen, Germany, has made significant strides in the field of medicinal chemistry. As an inventor with a focus on quinazoline derivatives, his work holds promise for innovative treatments in the medical sector. He is affiliated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company dedicated to researching and developing innovative therapies.
Latest Patents
Cartsen Reichel is credited with one notable patent titled "Process for preparing aminocrotonylamino-substituted quinazoline derivatives." This patent outlines an improved methodology for synthesizing aminocrotonylamino-substituted quinazoline derivatives of the general formula (I). The invention focuses on derivatives that serve as inhibitors of signal transduction pathways mediated by tyrosine kinases and the Epidermal Growth Factor-Receptor (EGF-R). These compounds are particularly relevant for treating tumoral diseases, highlighting the therapeutic potential of his work.
Career Highlights
Reichel's career is marked by his contributions to the pharmaceutical industry, particularly through his position at Boehringer Ingelheim. His innovative approaches to drug development particularly impact the treatment of cancer, as evidenced by his patent. His expertise underscores his role as an influential inventor in his field.
Collaborations
Throughout his career, Cartsen has collaborated with notable colleagues, including Juergen Schroeder and Georg Dziewas. These collaborations are vital in the advancement of research projects, combining their expertise to push the boundaries of medicinal chemistry and improve patient outcomes.
Conclusion
Cartsen Reichel’s contributions to the field of pharmacology through his patent for quinazoline derivatives exemplify the intersection of innovation and medical research. His work at Boehringer Ingelheim continues to inspire advancements in therapies for challenging diseases, demonstrating the significant impact that inventors like him have on healthcare and the future of medicine.